Thursday, November 5, 2026
Via News Knowledge File

Netflix Inc.

organization80% conf.·synced Nov 5, 2026

Streaming entertainment service company

60
sourced metrics
1017
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
66.39USD
Nov 4, 2026reference only
Market Cap
276443955090USD
Nov 4, 2026reference only
Stock Return Ytd
-27.0%
Nov 4, 2026reference only
Price 52 Week Low
61.99USD
Nov 4, 2026reference only
Price 52 Week High
1157.50USD
Nov 4, 2026reference only
Stockholders Equity
30152052000.0USD
Jun 30, 2026reference only
Shares Outstanding
4163939676.0shares
Jun 30, 2026reference only
Eps
0.8USD_per_share
Jun 30, 2026reference only
Cash
9099232000.0USD
Jun 30, 2026reference only
Rd Expense
1007675000.0USD
Jun 30, 2026reference only
Operating Cash Flow
1743812000.0USD
Jun 30, 2026reference only
Revenue
12559938000.0USD
Jun 30, 2026reference only
Total Assets
58450441000.0USD
Jun 30, 2026reference only
Capex
218644000.0USD
Jun 30, 2026reference only
Net Income
3401414000.0USD
Jun 30, 2026reference only
Cost Of Revenue
6036965000.0USD
Jun 30, 2026reference only
Operating Income
4192610000.0USD
Jun 30, 2026reference only
Total Liabilities
28298389000.0USD
Jun 30, 2026reference only

Stated objectives

Achieve 31.5% operating margin

source
target: 31.5% by 2026-01-01 00:00:00stated

Achieve $3 billion in ad revenue (doubling from 2025)

source
target: 3 billion USD by 2026-01-01 00:00:00stated

Achieve 14% year-over-year revenue growth

source
target: 14% by 2026-01-01 00:00:00stated

Maintain content cash spend at $17 billion (growing slower than revenue)

source
target: 17 billion USD by 2026-01-01 00:00:00stated

Generate approximately $6 billion in free cash flow

source
target: 6 billion USD by 2026-01-01 00:00:00stated

Roll out proprietary ad tech stack to all ad markets

source
target: 12 countries by 2025-01-01 00:00:00stated

Add 2+ live operation centers in UK and Asia

source
target: 2+ by 2026-01-01 00:00:00stated

Operating margin guidance for Q1

source
target: 32.1% by 2026-01-01 00:00:00stated

Q1 2026 operating margin guidance

source
target: 32.1% by 2026-01-01 00:00:00stated

Q1 2026 operating margin

source
target: 32.1% stated

Relationship graph · 1017 connections

Covered by
417
Competes with
149
Developed by
47
Employs
46
rates
45
acquired by
40
Invested in
22
founded
22

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com